Effect of anatomical change on dose distribution during radiotherapy for maxillary sinus carcinoma: passive scattering proton therapy versus volumetric-modulated arc therapy.


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
Jan 2019
Historique:
medline: 4 10 2018
pubmed: 4 10 2018
entrez: 4 10 2018
Statut: ppublish

Résumé

Maxillary sinus carcinomas are anatomically situated next to many organs at risk (OARs), and anatomical change is often observed during radiotherapy. We analyzed the effect of anatomical change on dose distribution of passive scattering proton therapy (PSPT) and volumetric-modulated arc therapy (VMAT) for 20 patients. The first plans were generated based on the first CT images. The second CT images were acquired after 3 weeks, and the second plans were generated by copying the first plans to the second CT images. The effect of anatomical change was estimated by comparing both plans. Target volume change was observed in all cases, however, the influence on dose coverage of clinical target volume tended to be small. Alternatively, the doses to almost all OARs were increased. In particular, the increase in the dose to brainstem ( PSPT was confirmed to be more effective than VMAT even the effect of anatomical change was taken into account. Therefore, it is expected that the contralateral vision can be preserved reliably while optimal target coverage is provided. PSPT allowed significant sparing of OARs even in the result of the second plans affected by the anatomical change. PSPT offers benefits over VMAT in reducing dose to several OARs.

Identifiants

pubmed: 30281327
doi: 10.1259/bjr.20180273
pmc: PMC6435060
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20180273

Auteurs

Yuki Narita (Y)

Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.
Department of Radiological Life Sciences, Division of Medical Life Sciences, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori, Japan.

Takahiro Kato (T)

Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.
Preparing Section for New Faculty of Medical Science, Fukushima Medical University, Fukushima, Fukushima, Japan.

Takashi Ono (T)

Departmentof Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Sho Oyama (S)

Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Shinya Komori (S)

Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Kazuhiro Arai (K)

Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Yoshitomo Abe (Y)

Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Takaomi Harada (T)

Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Tatsuya Nakamura (T)

Departmentof Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Hitoshi Wada (H)

Departmentof Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Yasuhiro Kikuchi (Y)

Departmentof Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Masao Murakami (M)

Departmentof Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Japan.

Yoichiro Hosokawa (Y)

Department of Radiological Life Sciences, Division of Medical Life Sciences, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori, Japan.

Classifications MeSH